You are here: Industry Insights > COVID-19

News List

Why COVID-19 presents a golden opportunity to Indian pharma firms expresspharma
September 17, 2020
India is among the leaders in the global pharma industry, being the third-largest producer in terms of volume and at the 10th position in terms of value.
Verona begins pilot study of potential COVID-19 inhaler pharmatimes
September 17, 2020
Verona Pharma has kicked off a pilot study to investigate the efficacy and safety of ensifentrine delivered via pressurised metered-dose inhaler (pMDI) formulation in patients hospitalised with COVID-19.
Avacta to Launch SARS-CoV-2 ELISA Laboratory Test americanpharmaceuticalreview
September 17, 2020
Avacta, the developer of Affimer? biotherapeutics and reagents, has announced it will launch an ELISA laboratory test for the SARS-CoV-2 spike protein to support global research efforts into the coronavirus that causes COVID-19.
FDA Releases COVID-19 Response At-A-Glance Summary americanpharmaceuticalreview
September 17, 2020
?The U.S. Food and Drug Administration (FDA), along with other federal, state, and local agencies and public health officials across the country, continues critical work to protect public health during the pandemic of COVID-19.
Avacta to Launch SARS-CoV-2 ELISA Lab Test contractpharma
September 17, 2020
To make a high performance Affimer research ELISA test available to support global research efforts to combat the coronavirus.
AMRI to Provide Sterile Fill/Finish Mfg. for AstraZeneca’s COVID-19 Vax contractpharma
September 17, 2020
To supply the vaccine candidate AZD1222 from AMRI’s drug product manufacturing facility in Albuquerque, NM.
Experimental COVID-19 Drug Shows Promise in Preliminary Cell Research prnewswire
September 16, 2020
An early study in human cells found that an antiviral drug candidate, Pfizer Inc.'s PF-00835231, may be at least as potent as the drug remdesivir in blocking the reproduction of the virus that causes COVID-19.
Tiny antibody component highly effective against SARS-COV-2 in animal studies worldpharmanews
September 16, 2020
University of Pittsburgh School of Medicine scientists have isolated the smallest biological molecule to date that completely and specifically neutralizes the SARS-CoV-2 virus, which is the cause of COVID-19.
NIH launches antithrombotics trials in COVID-19 patients europeanpharmaceuticalreview
September 16, 2020
The adaptive Phase III trials will assess whether various types and doses of blood thinners can prevent COVID-19 patients forming potentially fatal blood clots.
A third of UK doctors have treated COVID-19 patients without full PPE, report finds pharmatimes
September 16, 2020
A new report has found that more than a third of UK doctors have treated COVID-19 patients in person without sufficient personal protective equipment (PPE) during the pandemic.